课题基金 / 基金详情

Regulation of mitochondrial calcium signaling by Pannexin2

Regulation of mitochondrial calcium signaling by Pannexin2
Pannexin2 对线粒体钙信号传导的调节
批准号:
RGPIN-2016-05471
负责人:
Naus, Christian
金额:
$2.77万
依托单位国家:
加拿大
项目类别:
Discovery Grants Program - Individual
财政年份:
2018
资助国家:
加拿大
项目状态:
已结题
起止时间:
2018-01-01 至 2019-12-31

项目摘要

项目成果

Naus, Christian的其他基金

相似基金

相关文献

中文摘要
翻译
***0*1*242*1382*11*3*1621*14.0***正常*0***FALSE**EN-US*ZH-CN*X-NONE******/**样式定义*/*表。MsoNormal表*{mso-style-name:“表正常”;*mso-tstyle-rowband-size:0;*mso-tstyle-colband-size:0;*mso-style-noshow:yes;*mso-style-first:99;*mso-style-Parent:“”;*mso-pending-alt:0 cm 5.4pt 0 cm 5.4pt;*mso-para-边距-top:0 cm;*mso-para-边距-right:0 cm;*mso-para-边距-Bottom:10.0pt;*mso-par-边距-Left:0 cm;*Text-Align:对齐;*Text-Align:Interdeoggraph;*文本缩进:36.0pt;*mso-PAGING:寡妇-孤儿;*字体-大小:12.0pt;*font-Family:“Times New Roman”;*mso-ansi-language:EN-US;*mso-fareast-language:ZH-CN;}*pannins是与缝隙连接蛋白连接蛋白家族相关的通道蛋白。与连接蛋白不同,Pannexins*不是来自两个相邻细胞之间的链接,而是直接连接到细胞的外部环境。然而,我们最近发现,PAnnexins中的一个成员Panx2仅限于细胞内部。最重要的是,它与线粒体密切相关,线粒体是细胞的能量源泉。线粒体缺陷与包括阿尔茨海默氏症和帕金森氏症在内的脑部疾病有关。由于pAnnexin*通道对钙离子具有通透性,我们假设在正常情况下,Panx2通道的活性通过调节线粒体的钙水平来调节线粒体能量的产生。相反,在病理条件下,Panx2通道活性的失调会触发线粒体钙超载,导致细胞死亡。我们建议从三个相互关联的目标来检验这一假设。在目标1中,我们将研究线粒体能量产生的改变是否会导致Panx2*表达和分布的变化。如果Panx2的增加与线粒体功能障碍有关,我们将确定Panx2是否调节Aim 2中能量分子ATP的产生。在确认Panx2在线粒体信号转导中的关键作用后,我们将研究Panx2活性*是否影响Aim 3中的线粒体钙水平。我们的建议*的发现将揭示抑制线粒体功能障碍的新策略,并为可能的脑部疾病治疗干预奠定基础。*
英文摘要
** * 0* 0* 1* 242* 1382* 11* 3* 1621* 14.0* * * * * *** * Normal* 0* * * * * false* false* false* * EN-US* ZH-CN* X-NONE* * * * * * * * * * * * * * * * * * * * * * * * * ** * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * **** /* Style Definitions */*table.MsoNormalTable* {mso-style-name:"Table Normal";* mso-tstyle-rowband-size:0;* mso-tstyle-colband-size:0;* mso-style-noshow:yes;* mso-style-priority:99;* mso-style-parent:"";* mso-padding-alt:0cm 5.4pt 0cm 5.4pt;* mso-para-margin-top:0cm;* mso-para-margin-right:0cm;* mso-para-margin-bottom:10.0pt;* mso-para-margin-left:0cm;* text-align:justify;* text-justify:inter-ideograph;* text-indent:36.0pt;* mso-pagination:widow-orphan;* font-size:12.0pt;* font-family:"Times New Roman";* mso-ansi-language:EN-US;* mso-fareast-language:ZH-CN;}*******Pannexins are channel proteins that are*related to the connexin family of gap junction proteins. Unlike connexins, pannexins*do not from a link between two adjacent cells but connect directly to the external*environment of the cells. However, we recently showed that one member of the*pannexins, Panx2, is restricted to the interior of the cell. Most importantly,*it is closely associated with mitochondria, the energy powerhouse of the cell. Defects in mitochondria are implicated in*brain disorders including Alzheimer's and Parkinson's disease. Since pannexin*channels have been reported to be permeable to calcium ions, we hypothesize*that under normal conditions Panx2 channel activity regulate mitochondrial*energy production by regulating mitochondrial calcium levels. In contrast,*under pathological conditions, dysregulation of Panx2 channel activity triggers*mitochondrial calcium overload leading to cell death. We propose to test this*hypothesis in three interrelated aims. In Aim 1, we will examine whether*alteration of mitochondrial energy production will lead to changes in Panx2*expression and distribution. If an increase in Panx2 is related to*mitochondrial dysfunction, we will determine whether Panx2 modulates the*production of energy molecule ATP in Aim 2. After confirming the critical role*of Panx2 in mitochondrial signaling, we will investigate whether Panx2 activity*influences the level mitochondrial calcium in Aim 3. Findings from our proposal*will reveal novel strategies to curtail mitochondrial dysfunction and lay the*foundation of possible therapeutic interventions in brain diseases. *** *
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Regulation of mitochondrial calcium signaling by Pannexin2
  • 批准号:
    RGPIN-2016-05471
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $2.77万
  • 财政年份:
    2021
  • 负责人:
    Naus, Christian
  • 依托单位:
Regulation of mitochondrial calcium signaling by Pannexin2
  • 批准号:
    RGPIN-2016-05471
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $2.77万
  • 财政年份:
    2020
  • 负责人:
    Naus, Christian
  • 依托单位:
Regulation of mitochondrial calcium signaling by Pannexin2
  • 批准号:
    RGPIN-2016-05471
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $2.77万
  • 财政年份:
    2019
  • 负责人:
    Naus, Christian
  • 依托单位:
Regulation of mitochondrial calcium signaling by Pannexin2
  • 批准号:
    RGPIN-2016-05471
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $2.77万
  • 财政年份:
    2017
  • 负责人:
    Naus, Christian
  • 依托单位:
国内基金
海外基金
Mitochondrial/MANF靶向调控β细胞NRF2表达减轻高糖与ROS对胰岛损伤的实验研究
  • 批准号:
    82502584
  • 项目类别:
    青年科学基金项目(C类)
  • 资助金额:
    30.00万元
  • 批准年份:
    2025
  • 负责人:
    徐阳
  • 依托单位:
糖尿病ED中成纤维细胞衰老调控内皮细胞线粒体稳态失衡的机制研究
  • 批准号:
    82371634
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    赵福军
  • 依托单位:
Idh3a作为线粒体代谢—表观遗传检查点调控产热脂肪功能的机制研究
  • 批准号:
    82370851
  • 项目类别:
    面上项目
  • 资助金额:
    48.00万元
  • 批准年份:
    2023
  • 负责人:
    包玉倩
  • 依托单位:
胆固醇合成蛋白CYP51介导线粒体通透性转换诱发Th17/Treg细胞稳态失衡在舍格伦综合征中的作用机制研究
  • 批准号:
    82370976
  • 项目类别:
    面上项目
  • 资助金额:
    48.00万元
  • 批准年份:
    2023
  • 负责人:
    郑凌艳
  • 依托单位: